{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:45:59Z","timestamp":1792118759782,"version":"4.4.0"},"reference-count":101,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/ccct1933","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:18:11Z","timestamp":1748578691000},"page":"2004-2021","source":"Crossref","is-referenced-by-count":6,"title":["Cholesterol metabolism reprogramming in multiple myeloma: examining its specificity and impact on the immune microenvironment"],"prefix":"10.62347","volume":"15","author":[{"given":"Hongtao","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Silberstein J, Tuchman S and Grant SJ. What is multiple myeloma? JAMA 2022; 327: 497.","DOI":"10.1001\/jama.2021.25306"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-019-0807-5","article-title":"Incidence and mortality of multiple myeloma in china, 2006-2016: an analysis of the global burden of disease study 2016","volume":"12","author":"Liu","year":"2019","unstructured":"Liu J, Liu W, Mi L, Zeng X, Cai C, Ma J and Wang L; Union for China Lymphoma Investigators of the Chinese Society of Clinical Oncology; Union for China Leukemia Investigators of the Chinese Society of Clinical Oncology. Incidence and mortality of multiple myeloma in china, 2006-2016: an analysis of the global burden of disease study 2016. J Hematol Oncol 2019; 12: 136.","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1097\/CM9.0000000000002600","article-title":"Burden of multiple myeloma in china: an analysis of the global burden of disease, injuries, and risk factors study 2019","volume":"136","author":"Liu","year":"2023","unstructured":"Liu J, Liu W, Mi L, Cai C, Gong T, Ma J and Wang L. Burden of multiple myeloma in china: an analysis of the global burden of disease, injuries, and risk factors study 2019. Chin Med J (Engl) 2023; 136: 2834-2838.","journal-title":"Chin Med J (Engl)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41408-022-00719-0","article-title":"Smoldering multiple myeloma current treatment algorithms","volume":"12","author":"Rajkumar","year":"2022","unstructured":"Rajkumar SV, Kumar S, Lonial S and Mateos MV. Smoldering multiple myeloma current treatment algorithms. Blood Cancer J 2022; 12: 129.","journal-title":"Blood Cancer J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","article-title":"Smoldering multiple myeloma","volume":"125","author":"SV","year":"2015","unstructured":"Rajkumar SV, Landgren O and Mateos MV. Smoldering multiple myeloma. Blood 2015; 125: 3069-3075.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","unstructured":"Huang B, Song BL and Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab 2020; 2: 132-141.","journal-title":"Nat Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","article-title":"Cholesterol metabolism: new functions and therapeutic approaches in cancer","volume":"1874","author":"Xu","year":"2020","unstructured":"Xu H, Zhou S, Tang Q, Xia H and Bi F. Cholesterol metabolism: new functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer 2020; 1874: 188394.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1038\/s41388-023-02836-x","article-title":"Dysregulation of cholesterol metabolism in cancer progression","volume":"42","author":"Liu","year":"2023","unstructured":"Liu X, Lv M, Zhang W and Zhan Q. Dysregulation of cholesterol metabolism in cancer progression. Oncogene 2023; 42: 3289-3302.","journal-title":"Oncogene"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","article-title":"Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis","volume":"15","author":"Xian","year":"2024","unstructured":"Xian M, Wang Q, Xiao L, Zhong L, Xiong W, Ye L, Su P, Zhang C, Li Y, Orlowski RZ, Zhan F, Ganguly S, Zu Y, Qian J and Yi Q. Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun 2024; 15: 5767.","journal-title":"Nat Commun"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.4158\/EP-2020-0347","article-title":"Cholesterol review: a metabolically important molecule","volume":"26","author":"DS","year":"2020","unstructured":"Schade DS, Shey L and Eaton RP. Cholesterol review: a metabolically important molecule. Endocr Pract 2020; 26: 1514-1523.","journal-title":"Endocr Pract"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.pharmthera.2023.108486","article-title":"The shared role of cholesterol in neuronal and peripheral inflammation","volume":"249","author":"Hansen","year":"2023","unstructured":"Hansen SB and Wang H. The shared role of cholesterol in neuronal and peripheral inflammation. Pharmacol Ther 2023; 249: 108486.","journal-title":"Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cvr\/cvac131","article-title":"Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans","volume":"119","author":"Ying","year":"2023","unstructured":"Ying Z, Tramper N, Zhou E, Boon MR, Rensen PCN and Kooijman S. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans. Cardiovasc Res 2023; 119: 905-918.","journal-title":"Cardiovasc Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","article-title":"Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer","volume":"12","author":"Liu","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY and Mcdonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun 2021; 12: 5103.","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/15548627.2023.2275501","article-title":"SREBF1\/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth","volume":"20","author":"Geng","year":"2024","unstructured":"Geng F and Guo D. SREBF1\/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth. Autophagy 2024; 20: 1183-1185.","journal-title":"Autophagy"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.2020.0150","article-title":"Association between genetically proxied inhibition of hmg-coa reductase and epithelial ovarian cancer","volume":"323","author":"Yarmolinsky","year":"2020","unstructured":"Yarmolinsky J, Bull CJ, Vincent EE, Robinson J, Walther A, Smith GD, Lewis SJ, Relton CL and Martin RM. Association between genetically proxied inhibition of hmg-coa reductase and epithelial ovarian cancer. JAMA 2020; 323: 646-655.","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.3390\/ijms241512032","article-title":"Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity","volume":"24","author":"Vassiliou","year":"2023","unstructured":"Vassiliou E and Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci 2023; 24: 12032.","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1182\/blood.2021013832","article-title":"Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins","volume":"139","author":"Panaroni","year":"2022","unstructured":"Panaroni C, Fulzele K, Mori T, Siu KT, Onyewadume C, Maebius A and Raje N. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood 2022; 139: 876-888.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1038\/s41598-023-46426-z","article-title":"Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma","volume":"13","author":"Zhao","year":"2023","unstructured":"Zhao N, Qu C, Yang Y, Li H, Li Y, Zhu H and Long Z. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma. Sci Rep 2023; 13: 19395.","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3390\/jcm11092513","article-title":"The leading role of the immune microenvironment in multiple myeloma: a new target with a great prognostic and clinical value","volume":"11","author":"Desantis","year":"2022","unstructured":"Desantis V, Savino FD, Scaringella A, Potenza MA, Nacci C, Frassanito MA, Vacca A and Montagnani M. The leading role of the immune microenvironment in multiple myeloma: a new target with a great prognostic and clinical value. J Clin Med 2022; 11: 2513.","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Schinke C and Weinhold N. The immune microenvironment in multiple myeloma progression at a single-cell level. Hemasphere 2023; 7: e894.","DOI":"10.1097\/HS9.0000000000000894"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1568009617666170214102301","article-title":"Multiple myeloma and the immune microenvironment","volume":"17","author":"Kawano","year":"2017","unstructured":"Kawano Y, Roccaro AM, Ghobrial IM and Azzi J. Multiple myeloma and the immune microenvironment. Curr Cancer Drug Targets 2017; 17: 806-818.","journal-title":"Curr Cancer Drug Targets"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.ajpath.2016.04.003","article-title":"Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma","volume":"186","author":"Herrero","year":"2016","unstructured":"Herrero AB, Garcia-Gomez A, Garayoa M, Corchete LA, Hernandez JM, San MJ and Gutierrez NC. Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma. Am J Pathol 2016; 186: 2171-2182.","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers13020164","article-title":"PD-L1\/PD-1 axis in multiple myeloma microenvironment and a possible link with cd38-mediated immune-suppression","volume":"13","author":"Costa","year":"2021","unstructured":"Costa F, Marchica V, Storti P, Malavasi F and Giuliani N. PD-L1\/PD-1 axis in multiple myeloma microenvironment and a possible link with cd38-mediated immune-suppression. Cancers (Basel) 2021; 13: 164.","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X and Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond) 2018; 38: 27.","journal-title":"Cancer Commun (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Wu L, Liu X, Lei J, Zhang N, Zhao H, Zhang J, Deng H and Li Y. Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells. J Immunother Cancer 2023; 11: e008081.","DOI":"10.1136\/jitc-2023-008081"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1530\/ERC-18-0572","article-title":"Host CYP27A1 expression is essential for ovarian cancer progression","volume":"26","author":"He","year":"2019","unstructured":"He S, Ma L, Baek AE, Vardanyan A, Vembar V, Chen JJ, Nelson AT, Burdette JE and Nelson ER. Host CYP27A1 expression is essential for ovarian cancer progression. Endocr Relat Cancer 2019; 26: 659-675.","journal-title":"Endocr Relat Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jare.2024.02.009","article-title":"Targeting lipid metabolism of macrophages: a new strategy for tumor therapy","volume":"68","author":"Shao","year":"2025","unstructured":"Shao N, Qiu H, Liu J, Xiao D, Zhao J, Chen C, Wan J, Guo M, Liang G, Zhao X and Xu L. Targeting lipid metabolism of macrophages: a new strategy for tumor therapy. J Adv Res 2025; 68: 99-114.","journal-title":"J Adv Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/imr.13215","article-title":"Lipid metabolism in dendritic cell biology","volume":"317","author":"You","year":"2023","unstructured":"You Z and Chi H. Lipid metabolism in dendritic cell biology. Immunol Rev 2023; 317: 137-151.","journal-title":"Immunol Rev"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Tavazoie MF, Pollack I, Tanqueco R, Ostendorf BN, Reis BS, Gonsalves FC, Kurth I, Andreu-Agullo C, Derbyshire ML, Posada J, Takeda S, Tafreshian KN, Rowinsky E, Szarek M, Waltzman RJ, Mcmillan EA, Zhao C, Mita M, Mita A, Chmielowski B, Postow MA, Ribas A, Mucida D and Tavazoie SF. LXR\/ApoE activation restricts innate immune suppression in cancer. Cell 2018; 172: 825-840, e18.","DOI":"10.1016\/j.cell.2017.12.026"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/2326-6066.CIR-19-0036","article-title":"Disrupting LILRB4\/APOE interaction by an efficacious humanized antibody reverses T-cell suppression and blocks AML development","volume":"7","author":"Gui","year":"2019","unstructured":"Gui X, Deng M, Song H, Chen Y, Xie J, Li Z, He L, Huang F, Xu Y, Anami Y, Yu H, Yu C, Li L, Yuan Z, Xu X, Wang Q, Chai Y, Huang T, Shi Y, Tsuchikama K, Liao XC, Xia N, Gao GF, Zhang N, Zhang CC and An Z. Disrupting LILRB4\/APOE interaction by an efficacious humanized antibody reverses T-cell suppression and blocks AML development. Cancer Immunol Res 2019; 7: 1244-1257.","journal-title":"Cancer Immunol Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, Meng X, Li L, Wang J, Xu C, Yan C, Wang L, Chang CC, Chang TY, Zhang T, Zhou P, Song BL, Liu W, Sun SC, Liu X, Li BL and Xu C. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature 2016; 531: 651-655.","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1038\/s41467-020-17179-4","article-title":"Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate","volume":"11","author":"Bibby","year":"2020","unstructured":"Bibby JA, Purvis HA, Hayday T, Chandra A, Okkenhaug K, Rosenzweig S, Aksentijevich I, Wood M, Lachmann HJ, Kemper C, Cope AP and Perucha E. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat Commun 2020; 11: 3412.","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"682911","DOI":"10.3389\/fonc.2021.682911","article-title":"Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy","volume":"11","author":"Giacomini","year":"2021","unstructured":"Giacomini I, Gianfanti F, Desbats MA, Orso G, Berretta M, Prayer-Galetti T, Ragazzi E and Cocetta V. Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy. Front Oncol 2021; 11: 682911.","journal-title":"Front Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/nu11061394","article-title":"Modulation of bone and marrow niche by cholesterol","volume":"11","author":"Yin","year":"2019","unstructured":"Yin W, Li Z and Zhang W. Modulation of bone and marrow niche by cholesterol. Nutrients 2019; 11: 1394.","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Guan Y, Liu X, Yang Z, Zhu X, Liu M, Du M, Pan X and Wang Y. Pcsk9 promotes LDLR degradation by preventing SNX17-mediated LDLR recycling. Circulation 2025; [Epub ahead of print].","DOI":"10.1161\/CIRCULATIONAHA.124.072336"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/neuonc\/noad060","article-title":"Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake","volume":"25","author":"Gu","year":"2023","unstructured":"Gu D, Zhou F, You H, Gao J, Kang T, Dixit D, Wu Q, Yang K, Ci S, Shan D, Fan X, Yuan W, Zhang Q, Lu C, Li D, Zhao N, Shi Z, Gao W, Lin F, Man J, Wang Q, Qian X, Mack SC, Tao W, Agnihotri S, Zhang N, You Y, Rich JN, Zhang J and Wang X. Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake. Neuro Oncol 2023; 25: 1578-1591.","journal-title":"Neuro Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/bs.pmbts.2022.07.008","article-title":"Endocytosis of LXRs: signaling in liver and disease","volume":"194","author":"Brahma","year":"2023","unstructured":"Brahma M, Ghosal S, Maruthi M and Kalangi SK. Endocytosis of LXRs: signaling in liver and disease. Prog Mol Biol Transl Sci 2023; 194: 347-375.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbrc.2017.02.003","article-title":"25-hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells","volume":"484","author":"Chen","year":"2017","unstructured":"Chen L, Zhang L, Xian G, Lv Y, Lin Y and Wang Y. 25-hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells. Biochem Biophys Res Commun 2017; 484: 857-863.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/bs.vh.2023.05.006","article-title":"A cholesterol-centric outlook on steroidogenesis","volume":"124","author":"Sidhu","year":"2024","unstructured":"Sidhu SK and Mishra S. A cholesterol-centric outlook on steroidogenesis. Vitam Horm 2024; 124: 405-428.","journal-title":"Vitam Horm"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1157969","DOI":"10.3389\/fendo.2023.1157969","article-title":"Vitamin d deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis","volume":"14","author":"Bao","year":"2023","unstructured":"Bao L, Wang YT, Lu MQ, Chu B, Shi L, Gao S, Fang LJ, Xiang QQ, Ding YH, Liu X, Zhao X, Wang MZ, Chen Y and Hu WK. Vitamin d deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis. Front Endocrinol (Lausanne) 2023; 14: 1157969.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Liu X, Xu P, Wang L, Zhang C, Wang M, Ouyang J and Chen B. Cholesterol levels provide prognostic information in patients with multiple myeloma. Clin Lab 2020; 66.","DOI":"10.7754\/Clin.Lab.2019.190824"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00277-011-1246-8","article-title":"Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells","volume":"91","author":"Tirado-Velez","year":"2012","unstructured":"Tirado-Velez JM, Benitez-Rondan A, Cozar-Castellano I, Medina F and Perdomo G. Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells. Ann Hematol 2012; 91: 83-88.","journal-title":"Ann Hematol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41375-020-0962-2","article-title":"The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma","volume":"35","author":"Longo","year":"2021","unstructured":"Longo J, Smirnov P, Li Z, Branchard E, van Leeuwen JE, Licht JD, Haibe-Kains B, Andrews DW, Keats JJ, Pugh TJ, Trudel S and Penn LZ. The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia 2021; 35: 796-808.","journal-title":"Leukemia"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1182\/blood-2003-12-4218","article-title":"The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of rho protein and activation of Rho kinase","volume":"104","author":"Schmidmaier","year":"2004","unstructured":"Schmidmaier R, Baumann P, Simsek M, Dayyani F, Emmerich B and Meinhardt G. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of rho protein and activation of Rho kinase. Blood 2004; 104: 1825-1832.","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.122.059062","article-title":"Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling","volume":"147","author":"Canfran-Duque","year":"2023","unstructured":"Canfran-Duque A, Rotllan N, Zhang X, Andres-Blasco I, Thompson BM, Sun J, Price NL, Fernandez-Fuertes M, Fowler JW, Gomez-Coronado D, Sessa WC, Giannarelli C, Schneider RJ, Tellides G, Mcdonald JG, Fernandez-Hernando C and Suarez Y. Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling. Circulation 2023; 147: 388-408.","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2741\/4216","article-title":"Physiological and pathological implications of cholesterol","volume":"19","author":"Cortes","year":"2014","unstructured":"Cortes VA, Busso D, Maiz A, Arteaga A, Nervi F and Rigotti A. Physiological and pathological implications of cholesterol. Front Biosci (Landmark Ed) 2014; 19: 416-428.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/molecules27020523","article-title":"The bioavailability and biological activities of phytosterols as modulators of cholesterol metabolism","volume":"27","author":"Li","year":"2022","unstructured":"Li X, Xin Y, Mo Y, Marozik P, He T and Guo H. The bioavailability and biological activities of phytosterols as modulators of cholesterol metabolism. Molecules 2022; 27: 523.","journal-title":"Molecules"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","unstructured":"Yavasoglu I, Tombuloglu M, Kadikoylu G, Donmez A, Cagirgan S and Bolaman Z. Cholesterol levels in patients with multiple myeloma. Ann Hematol 2008; 87: 223-228.","journal-title":"Ann Hematol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1158\/0008-5472.CAN-20-3323","article-title":"Treatment with HIV-protease inhibitor nelfinavir identifies membrane lipid composition and fluidity as a therapeutic target in advanced multiple myeloma","volume":"81","author":"Besse","year":"2021","unstructured":"Besse L, Besse A, Stolze SC, Sobh A, Zaal EA, van der Ham AJ, Ruiz M, Phuyal S, Buchler L, Sathianathan M, Florea BI, Boren J, Stahlman M, Huber J, Bolomsky A, Ludwig H, Hannich JT, Loguinov A, Everts B, Berkers CR, Pilon M, Farhan H, Vulpe CD, Overkleeft HS and Driessen C. Treatment with HIV-protease inhibitor nelfinavir identifies membrane lipid composition and fluidity as a therapeutic target in advanced multiple myeloma. Cancer Res 2021; 81: 4581-4593.","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/biof.5520160301","article-title":"Membrane-rigidifying effects of anti-cancer dietary factors","volume":"16","author":"Tsuchiya","year":"2002","unstructured":"Tsuchiya H, Nagayama M, Tanaka T, Furusawa M, Kashimata M and Takeuchi H. Membrane-rigidifying effects of anti-cancer dietary factors. Biofactors 2002; 16: 45-56.","journal-title":"Biofactors"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/ijc.22478","article-title":"Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo","volume":"120","author":"Edwards","year":"2007","unstructured":"Edwards CM, Mueller G, Roelofs AJ, Chantry A, Perry M, Russell RG, Van Camp B, Guyon-Gellin Y, Niesor EJ, Bentzen CL, Vanderkerken K and Croucher PI. Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo. Int J Cancer 2007; 120: 1657-1663.","journal-title":"Int J Cancer"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"114654","DOI":"10.1016\/j.bcp.2021.114654","article-title":"Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs","volume":"196","author":"Patel","year":"2022","unstructured":"Patel KK and Kashfi K. Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol 2022; 196: 114654.","journal-title":"Biochem Pharmacol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1600-0625.2009.00850.x","article-title":"Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells","volume":"18","author":"Schallreuter","year":"2009","unstructured":"Schallreuter KU, Hasse S, Rokos H, Chavan B, Shalbaf M, Spencer JD and Wood JM. Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Exp Dermatol 2009; 18: 680-688.","journal-title":"Exp Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"215884","DOI":"10.1016\/j.canlet.2022.215884","article-title":"NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A\/MEK\/ERK\/c-Jun\/abca1 pathway mediated membrane fluidity","volume":"547","author":"Wang","year":"2022","unstructured":"Wang Y, Zhou X, Lei Y, Chu Y, Yu X, Tong Q, Zhu T, Yu H, Fang S, Li G, Wang L, Wang GY, Xie X and Zhang J. NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A\/MEK\/ERK\/c-Jun\/abca1 pathway mediated membrane fluidity. Cancer Lett 2022; 547: 215884.","journal-title":"Cancer Lett"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3724\/zdxbyxb-2021-0033","article-title":"Cholesterol metabolism and tumor","volume":"50","author":"Meng","year":"2021","unstructured":"Meng Y, Wang Q and Lyu Z. Cholesterol metabolism and tumor. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021; 50: 23-31.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7453\/gahmj.2012.1.2.008","article-title":"Statin-induced myopathy","volume":"1","author":"Fitzgerald","year":"2012","unstructured":"Fitzgerald K, Redmond E and Harbor C. Statin-induced myopathy. Glob Adv Health Med 2012; 1: 32-36.","journal-title":"Glob Adv Health Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","unstructured":"Apostolopoulou M, Corsini A and Roden M. The role of mitochondria in statin-induced myopathy. Eur J Clin Invest 2015; 45: 745-754.","journal-title":"Eur J Clin Invest"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.redox.2016.08.007","article-title":"The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic beta-cells, glycemic control and inflammation: in vitro and in vivo studies","volume":"9","author":"Carrasco-Pozo","year":"2016","unstructured":"Carrasco-Pozo C, Tan KN, Reyes-Farias M, De La Jara N, Ngo ST, Garcia-Diaz DF, Llanos P, Cires MJ and Borges K. The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic beta-cells, glycemic control and inflammation: in vitro and in vivo studies. Redox Biol 2016; 9: 229-243.","journal-title":"Redox Biol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"19834","DOI":"10.1038\/s41598-020-76224-w","article-title":"Platycodin D enhances LDLR expression and LDL uptake via down-regulation of idol mRNA in hepatic cells","volume":"10","author":"Choi","year":"2020","unstructured":"Choi YJ, Lee SJ, Kim HI, Lee HJ, Kang SJ, Kim TY, Cheon C and Ko S. Platycodin D enhances LDLR expression and LDL uptake via down-regulation of idol mRNA in hepatic cells. Sci Rep 2020; 10: 19834.","journal-title":"Sci Rep"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1038\/s41388-023-02762-y","article-title":"Pgc-1alpha promotes colorectal carcinoma metastasis through regulating ABCA1 transcription","volume":"42","author":"Chen","year":"2023","unstructured":"Chen W, Zhang Q, Dai X, Chen X, Zhang C, Bai R, Chen Y, Zhang K, Duan X, Qiao Y, Zhao J, Tian F, Liu K, Dong Z and Lu J. Pgc-1alpha promotes colorectal carcinoma metastasis through regulating ABCA1 transcription. Oncogene 2023; 42: 2456-2470.","journal-title":"Oncogene"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.cellbio.16.1.459","article-title":"The role of orphan nuclear receptors in the regulation of cholesterol homeostasis","volume":"16","author":"Repa","year":"2000","unstructured":"Repa JJ and Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000; 16: 459-481.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/CM9.0000000000002426","article-title":"Metabolic reprogramming in the immunosuppression of tumor-associated macrophages","volume":"135","author":"Wang","year":"2022","unstructured":"Wang Y, Wang D, Yang L and Zhang Y. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chin Med J (Engl) 2022; 135: 2405-2416.","journal-title":"Chin Med J (Engl)"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"216267","DOI":"10.1016\/j.canlet.2023.216267","article-title":"Lipid metabolism reprogramming of CD8(+) T cell and therapeutic implications in cancer","volume":"567","author":"Wang","year":"2023","unstructured":"Wang R, Liu Z, Fan Z and Zhan H. Lipid metabolism reprogramming of CD8(+) T cell and therapeutic implications in cancer. Cancer Lett 2023; 567: 216267.","journal-title":"Cancer Lett"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.ccell.2023.05.013","article-title":"Cholesterol atlas of tumor microenvironment provides route to improved CAR-T therapy","volume":"41","author":"Chaves-Filho","year":"2023","unstructured":"Chaves-Filho AB and Schulze A. Cholesterol atlas of tumor microenvironment provides route to improved CAR-T therapy. Cancer Cell 2023; 41: 1204-1206.","journal-title":"Cancer Cell"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"216208","DOI":"10.1016\/j.canlet.2023.216208","article-title":"Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion","volume":"564","author":"Chen","year":"2023","unstructured":"Chen Y, Xu Y, Zhao H, Zhou Y, Zhang J, Lei J, Wu L, Zhou M, Wang J, Yang S, Zhang X, Yan G and Li Y. Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. Cancer Lett 2023; 564: 216208.","journal-title":"Cancer Lett"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","article-title":"Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth","volume":"4","author":"Zhao","year":"2022","unstructured":"Zhao H, Teng D, Yang L, Xu X, Chen J, Jiang T, Feng AY, Zhang Y, Frederick DT, Gu L, Cai L, Asara JM, Pasca di Magliano M, Boland GM, Flaherty KT, Swanson KD, Liu D, Rabinowitz JD and Zheng B. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab 2022; 4: 1660-1673.","journal-title":"Nat Metab"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"22126","DOI":"10.1038\/s41598-024-73152-x","article-title":"Vitamin D(3) reduces the expression of M1 and M2 macrophage markers in breast cancer patients","volume":"14","author":"Stachowicz-Suhs","year":"2024","unstructured":"Stachowicz-Suhs M, Labedz N, Milczarek M, Klopotowska D, Filip-Psurska B, Maciejczyk A, Matkowski R and Wietrzyk J. Vitamin D(3) reduces the expression of M1 and M2 macrophage markers in breast cancer patients. Sci Rep 2024; 14: 22126.","journal-title":"Sci Rep"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, Wang Q, Yang M, Kalady MF, Qian J, Zhang A, Gupte AA, Hamilton DJ, Zheng C and Yi Q. Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab 2019; 30: 143-156, e5.","DOI":"10.1016\/j.cmet.2019.04.002"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang X, Chen K, Cheng Y, Liu S, Xia M, Chen Y, Zhu H, Li Z and Cao X. CCR7 chemokine receptor-inducible lnc-dpf3 restrains dendritic cell migration by inhibiting hif-1alphamediated glycolysis. Immunity 2019; 50: 600-615, e15.","DOI":"10.1016\/j.immuni.2019.01.021"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jpha.2023.08.002","article-title":"27-hydroxycholesterol\/liver X receptor\/apolipoprotein E mediates zearalenone-induced intestinal immunosuppression: a key target potentially linking zearalenone and cancer","volume":"14","author":"Ruan","year":"2024","unstructured":"Ruan H, Zhang J, Wang Y, Huang Y, Wu J, He C, Ke T, Luo J and Yang M. 27-hydroxycholesterol\/liver X receptor\/apolipoprotein E mediates zearalenone-induced intestinal immunosuppression: a key target potentially linking zearalenone and cancer. J Pharm Anal 2024; 14: 371-388.","journal-title":"J Pharm Anal"},{"key":"ref70","unstructured":"Shi SZ, Lee EJ, Lin YJ, Chen L, Zheng HY, He XQ, Peng JY, Noonepalle SK, Shull AY, Pei FC, Deng LB, Tian XL, Deng KY, Shi H and Xin HB. Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer. Am J Cancer Res 2019; 9: 2194-2208."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"101647","DOI":"10.1016\/j.tranon.2023.101647","article-title":"Retinoic acid-loaded plga nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer","volume":"31","author":"Junior","year":"2023","unstructured":"Junior RFA, Lira GA, Schomann T, Cavalcante RS, Vilar NF, de Paula RCM, Gomes RF, Chung CK, Jorquera-Cordero C, Vepris O, Chan AB and Cruz LJ. Retinoic acid-loaded plga nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer. Transl Oncol 2023; 31: 101647.","journal-title":"Transl Oncol"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Lu E, Dang EV, Mcdonald JG and Cyster JG. Distinct oxysterol requirements for positioning naive and activated dendritic cells in the spleen. Sci Immunol 2017; 2: eaal5237.","DOI":"10.1126\/sciimmunol.aal5237"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.4049\/jimmunol.179.9.5711","article-title":"Calcineurin inhibitors block MHC-restricted antigen presentation in vivo","volume":"179","author":"Lee","year":"2007","unstructured":"Lee YH, Lee YR, Im SA, Park SI, Kim KH, Gerelchuluun T, Song S, Kim K and Lee CK. Calcineurin inhibitors block MHC-restricted antigen presentation in vivo. J Immunol 2007; 179: 5711-5716.","journal-title":"J Immunol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2054879","DOI":"10.1155\/2022\/2054879","article-title":"Interleukin-27 ameliorates atherosclerosis in Apoe(-\/-) mice through regulatory t cell augmentation and dendritic cell tolerance","volume":"2022","author":"Xu","year":"2022","unstructured":"Xu W, Zhu R, Zhu Z, Yu K, Wang Y, Ding Y, Yu J, Tang H, Zeng Q and Zhong Y. Interleukin-27 ameliorates atherosclerosis in Apoe(-\/-) mice through regulatory t cell augmentation and dendritic cell tolerance. Mediators Inflamm 2022; 2022: 2054879.","journal-title":"Mediators Inflamm"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Pan H, Zheng Y, Pan Q, Chen H, Chen F, Wu J and Di D. Expression of LXR-beta, ABCA1 and ABCG1 in human triple-negative breast cancer tissues. Oncol Rep 2019; 42: 1869-1877.","DOI":"10.3892\/or.2019.7279"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/cei.12603","article-title":"Low programmed cell death-1 (pd-1) expression in peripheral CD4(+) T cells in japanese patients with autoimmune type 1 diabetes","volume":"180","author":"Fujisawa","year":"2015","unstructured":"Fujisawa R, Haseda F, Tsutsumi C, Hiromine Y, Noso S, Kawabata Y, Mitsui S, Terasaki J, Ikegami H, Imagawa A and Hanafusa T. Low programmed cell death-1 (pd-1) expression in peripheral CD4(+) T cells in japanese patients with autoimmune type 1 diabetes. Clin Exp Immunol 2015; 180: 452-457.","journal-title":"Clin Exp Immunol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cas.15999","article-title":"SCD1 inhibition enhances the effector functions of CD8(+) T cells via acat1-dependent reduction of esterified cholesterol","volume":"115","author":"Sugi","year":"2024","unstructured":"Sugi T, Katoh Y, Ikeda T, Seta D, Iwata T, Nishio H, Sugawara M, Kato D, Katoh K, Kawana K, Yaguchi T, Kawakami Y and Hirai S. SCD1 inhibition enhances the effector functions of CD8(+) T cells via acat1-dependent reduction of esterified cholesterol. Cancer Sci 2024; 115: 48-58.","journal-title":"Cancer Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-023-06483-w","article-title":"Metabolic programs of T cell tissue residency empower tumour immunity","volume":"621","author":"Reina-Campos","year":"2023","unstructured":"Reina-Campos M, Heeg M, Kennewick K, Mathews IT, Galletti G, Luna V, Nguyen Q, Huang H, Milner JJ, Hu KH, Vichaidit A, Santillano N, Boland BS, Chang JT, Jain M, Sharma S, Krummel MF, Chi H, Bensinger SJ and Goldrath AW. Metabolic programs of T cell tissue residency empower tumour immunity. Nature 2023; 621: 179-187.","journal-title":"Nature"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12944-024-02289-5","article-title":"Lipid levels and multiple myeloma risk: insights from meta-analysis and mendelian randomization","volume":"23","author":"Zhu","year":"2024","unstructured":"Zhu W, Charwudzi A, Li Q, Zhai Z, Hu L and Pu L. Lipid levels and multiple myeloma risk: insights from meta-analysis and mendelian randomization. Lipids Health Dis 2024; 23: 299.","journal-title":"Lipids Health Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cancers13030540","article-title":"Lipid level, lipid variability, and risk of multiple myeloma: a nationwide population-based study of 3,527,776 subjects","volume":"13","author":"Choi","year":"2021","unstructured":"Choi T, Choi IY, Han K, Jeong SM, Yoo JE, Rhee SY, Park YG and Shin DW. Lipid level, lipid variability, and risk of multiple myeloma: a nationwide population-based study of 3,527,776 subjects. Cancers (Basel) 2021; 13: 540.","journal-title":"Cancers (Basel)"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Veskovski L, Andersson PO, Turesson I, Malmodin D, Pedersen A and Mellqvist UH. Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Exp Hematol 2021; 97: 79-88, e8.","DOI":"10.1016\/j.exphem.2021.02.007"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1158\/0008-5472.CAN-14-0130","article-title":"Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop","volume":"74","author":"Pandyra","year":"2014","unstructured":"Pandyra A, Mullen PJ, Kalkat M, Yu R, Pong JT, Li Z, Trudel S, Lang KS, Minden MD, Schimmer AD and Penn LZ. Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop. Cancer Res 2014; 74: 4772-4782.","journal-title":"Cancer Res"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"101514","DOI":"10.1016\/j.molmet.2022.101514","article-title":"Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis","volume":"61","author":"Lee","year":"2022","unstructured":"Lee MKS, Cooney OD, Lin X, Nadarajah S, Dragoljevic D, Huynh K, Onda DA, Galic S, Meikle PJ, Edlund T, Fullerton MD, Kemp BE, Murphy AJ and Loh K. Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis. Mol Metab 2022; 61: 101514.","journal-title":"Mol Metab"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-981-19-1592-5_7","article-title":"ABCA1, ABCG1, and cholesterol homeostasis","volume":"1377","author":"XH","year":"2022","unstructured":"Yu XH and Tang CK. ABCA1, ABCG1, and cholesterol homeostasis. Adv Exp Med Biol 2022; 1377: 95-107.","journal-title":"Adv Exp Med Biol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canlet.2020.08.020","article-title":"27-hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression","volume":"493","author":"Ma","year":"2020","unstructured":"Ma L, Wang L, Nelson AT, Han C, He S, Henn MA, Menon K, Chen JJ, Baek AE, Vardanyan A, Shahoei SH, Park S, Shapiro DJ, Nanjappa SG and Nelson ER. 27-hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression. Cancer Lett 2020; 493: 266-283.","journal-title":"Cancer Lett"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1038\/s41598-023-46426-z","article-title":"Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma","volume":"13","author":"Zhao","year":"2023","unstructured":"Zhao N, Qu C, Yang Y, Li H, Li Y, Zhu H and Long Z. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma. Sci Rep 2023; 13: 19395.","journal-title":"Sci Rep"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","article-title":"Leukocyte immunoglobulin-like receptor b1 (lilrb1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis","volume":"15","author":"Xian","year":"2024","unstructured":"Xian M, Wang Q, Xiao L, Zhong L, Xiong W, Ye L, Su P, Zhang C, Li Y, Orlowski RZ, Zhan F, Ganguly S, Zu Y, Qian J and Yi Q. Leukocyte immunoglobulin-like receptor b1 (lilrb1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun 2024; 15: 5767.","journal-title":"Nat Commun"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000505992","article-title":"The association between metabolic syndrome and multiple myeloma","volume":"144","author":"Ragbourne","year":"2021","unstructured":"Ragbourne SC, Maghsoodi N, Streetly M and Crook MA. The association between metabolic syndrome and multiple myeloma. Acta Haematol 2021; 144: 24-33.","journal-title":"Acta Haematol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.3390\/foods12244424","article-title":"A general review of methodologies used in the determination of cholesterol (C(27)H(46)O) levels in foods","volume":"12","author":"Ndhlala","year":"2023","unstructured":"Ndhlala AR, Kavaz Yuksel A, Celebi N and Dogan HO. A general review of methodologies used in the determination of cholesterol (C(27)H(46)O) levels in foods. Foods 2023; 12: 4424.","journal-title":"Foods"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","unstructured":"Baek AE, Yu YA, He S, Wardell SE, Chang CY, Kwon S, Pillai RV, Mcdowell HB, Thompson JW, Dubois LG, Sullivan PM, Kemper JK, Gunn MD, Mcdonnell DP and Nelson ER. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun 2017; 8: 864.","journal-title":"Nat Commun"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.jlr.2021.100165","article-title":"Cholesterol metabolism: from lipidomics to immunology","volume":"63","author":"Griffiths","year":"2022","unstructured":"Griffiths WJ and Wang Y. Cholesterol metabolism: from lipidomics to immunology. J Lipid Res 2022; 63: 100165.","journal-title":"J Lipid Res"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Wu D and Chen Y. Lipids for CD8(+) TILs: beneficial or harmful? Front Immunol 2022; 13: 1020422.","DOI":"10.3389\/fimmu.2022.1020422"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1007\/s00262-023-03555-8","article-title":"Cholesterol induction in CD8(+) T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites","volume":"72","author":"Shuwen","year":"2023","unstructured":"Shuwen H, Yinhang W, Jing Z, Qiang Y, Yizhen J, Quan Q, Yin J, Jiang L and Xi Y. Cholesterol induction in CD8(+) T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites. Cancer Immunol Immunother 2023; 72: 4441-4456.","journal-title":"Cancer Immunol Immunother"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1158\/1078-0432.CCR-20-3863","article-title":"Crispr\/cas9-engineered universal CD19\/CD22 dual-targeted car-t cell therapy for relapsed\/refractory B-cell acute lymphoblastic leukemia","volume":"27","author":"Hu","year":"2021","unstructured":"Hu Y, Zhou Y, Zhang M, Ge W, Li Y, Yang L, Wei G, Han L, Wang H, Yu S, Chen Y, Wang Y, He X, Zhang X, Gao M, Yang J, Li X, Ren J and Huang H. Crispr\/cas9-engineered universal CD19\/CD22 dual-targeted car-t cell therapy for relapsed\/refractory B-cell acute lymphoblastic leukemia. Clin Cancer Res 2021; 27: 2764-2772.","journal-title":"Clin Cancer Res"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/leu.2015.157","article-title":"Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib","volume":"29","author":"Jagannathan","year":"2015","unstructured":"Jagannathan S, Abdel-Malek MA, Malek E, Vad N, Latif T, Anderson KC and Driscoll JJ. Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib. Leukemia 2015; 29: 2184-2191.","journal-title":"Leukemia"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Xiao J, Wang S, Chen L, Ding X, Dang Y, Han M, Zheng Y, Shen H, Wu S, Wang M, Yang D, Li N, Dong C, Hu M, Su C, Li W, Hui L, Ye Y, Tang H, Wei B and Wang H. 25-hydroxycholesterol regulates lysosome amp kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity 2024; 57: 1087-1104, e7.","DOI":"10.1016\/j.immuni.2024.03.021"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"159136","DOI":"10.1016\/j.bbalip.2022.159136","article-title":"Transcription of cytochrome p450 46a1 in nih3t3 cells is negatively regulated by FBS","volume":"1867","author":"Shinohara","year":"2022","unstructured":"Shinohara Y, Ando H, Maekawa M, Arai M, Horibata Y, Satou M, Jojima T, Usui I, Aso Y and Sugimoto H. Transcription of cytochrome p450 46a1 in nih3t3 cells is negatively regulated by FBS. Biochim Biophys Acta Mol Cell Biol Lipids 2022; 1867: 159136.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s13238-021-00821-2","article-title":"Potentiating CD8(+) T cell antitumor activity by inhibiting pcsk9 to promote LDLR-mediated TCR recycling and signaling","volume":"12","author":"Yuan","year":"2021","unstructured":"Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, Chen H, Lin H, Chen Z, Liu M, He S, Chen Q, Feng S, Wu Y, Zhang Z, Ding Y and Yang W. Potentiating CD8(+) T cell antitumor activity by inhibiting pcsk9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell 2021; 12: 240-260.","journal-title":"Protein Cell"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Banach M, Jaiswal V, Ang SP, Sawhney A, Deb N, Amarenco P, Gaita D, Reiner Z, Pecin I, Lavie CJ, Penson PE and Toth PP; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP). Impact of lipid-lowering combination therapy with statins and ezetimibe vs statin monotherapy on the reduction of cardiovascular outcomes: a meta-analysis. Mayo Clin Proc 2025; [Epub ahead of print].","DOI":"10.1016\/j.mayocp.2025.01.018"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-020-2445-z","article-title":"Self-assembled poly-catenanes from supramolecular toroidal building blocks","volume":"583","author":"Datta","year":"2020","unstructured":"Datta S, Kato Y, Higashiharaguchi S, Aratsu K, Isobe A, Saito T, Prabhu DD, Kitamoto Y, Hollamby MJ, Smith AJ, Dalgliesh R, Mahmoudi N, Pesce L, Perego C, Pavan GM and Yagai S. Self-assembled poly-catenanes from supramolecular toroidal building blocks. Nature 2020; 583: 400-405.","journal-title":"Nature"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/5\/ajcr0163423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:08Z","timestamp":1766023208000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/5\/ajcr0163423.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ccct1933","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}